Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rSIFN-co vs interferon alfa-2b for chronic hepatitis B
CTR20150734Phase 3Active
- Sponsor
- Sichuan Huiyang Life Engineering
- Start
- Nov 2015
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant super-compound interferon in Chronic Hepatitis B (CHB), sponsored by Sichuan Huiyang Life Engineering. Started Nov 2015; status: active.
02
Drugs
recombinant super-compound interferon
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20150734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150734.